Could an arthritis drug shield heart and kidneys in metabolic syndrome?
NCT ID NCT07704190
First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time
Summary
This study tests whether secukinumab, a drug that blocks inflammation, can reduce the risk of major heart problems and kidney decline in people with cardiorenal metabolic syndrome and hardened arteries. About 100 adults will receive either secukinumab injections plus standard care, or standard care alone, and be followed for two years. The main goal is to see if the drug delays heart attacks, strokes, or heart-related death.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- secukinumab, an injectable drug that blocks IL-17A to reduce inflammation
- What this could lead to
- If successful, this could show that targeting inflammation with secukinumab lowers the risk of heart attacks, strokes, and kidney decline in people with metabolic syndrome and heart disease.
- What could go wrong
- This is a small, early-phase trial with only 100 participants, so results may not apply broadly. The drug may not improve outcomes and could have side effects like infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can common heart-surgery practices trigger delirium? a 5,600-patient hunt for clues.
- Squeeze away hypertension? handgrip device put to the test
- Blood pressure cuffs and health classes: a new approach to close a heart health gap
- AI tailors lifestyle tips to tackle high blood pressure
- Can a drug that boosts red blood cells help anemia in kidney disease?
- Predicting kidney trouble in older adults: a data-driven approach to clearer lab results